Mechanism 04 Visceral Fat Reduction Tesamorelin, a GHRH analogue, is FDA-approved for visceral fat reduction and has been studied in non-HIV populations for its ability to reduce deep abdominal fat the metabolically dangerous kind
Ultimately, to make real progress, research must continue to explore the underlying mechanisms, conduct rigorous clinical trials, and address safety concerns.
How is Tesamorelin administered
Rigorously developed and intended solely for research purposes, Epithalon (or Epitalon) Nasal Spray contains the peptide Epithalon, renowned for its potential applications in various research fields
Such an amazing experience
For patients who struggle with insulin resistance, these medications provide a powerful solution that goes beyond glucose control